| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advances in immunotherapy in cervical cancer
|
Grau, Juan-Francisco
|
|
|
33 |
3 |
p. 403-413
|
article
|
| 2 |
Biomarker-driven therapy in endometrial cancer
|
Karpel, Hannah
|
|
|
33 |
3 |
p. 343-350
|
article
|
| 3 |
Genomic testing in high-grade serous ovarian cancer: current options and future development
|
Devlin, Michael-John
|
|
|
33 |
3 |
p. 358-363
|
article
|
| 4 |
Immunotherapy in endometrial cancer
|
Mahdi, Haider
|
|
|
33 |
3 |
p. 351-357
|
article
|
| 5 |
Integrating antibody drug conjugates in the management of gynecologic cancers
|
Chelariu-Raicu, Anca
|
|
|
33 |
3 |
p. 420-429
|
article
|
| 6 |
New therapies for clear cell ovarian carcinoma
|
Stewart, James
|
|
|
33 |
3 |
p. 385-393
|
article
|
| 7 |
Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy
|
Hennah, Lindsay
|
|
|
33 |
3 |
p. 414-419
|
article
|
| 8 |
Novel therapeutics in low-grade serous ovarian cancer
|
Cobb, Lauren
|
|
|
33 |
3 |
p. 377-384
|
article
|
| 9 |
Novel therapies leading to a new landscape in gynecologic tumors
|
Madariaga, Ainhoa
|
|
|
33 |
3 |
p. 321-322
|
article
|
| 10 |
Outcomes and endpoints of relevance in gynecologic cancer clinical trials
|
Madariaga, Ainhoa
|
|
|
33 |
3 |
p. 323-332
|
article
|
| 11 |
Overcoming PARP inhibitor resistance in ovarian cancer
|
Soberanis Pina, Pamela
|
|
|
33 |
3 |
p. 364-376
|
article
|
| 12 |
Update in the molecular classification of endometrial carcinoma
|
Léon-Castillo, Alicia
|
|
|
33 |
3 |
p. 333-342
|
article
|
| 13 |
Updates on cervical cancer prevention
|
Viveros-Carreño, David
|
|
|
33 |
3 |
p. 394-402
|
article
|
Journal description